Thank you, Jim, and good afternoon. As Jim discussed, we continue to remain active in the venture lending market at our platform TriplePoint Capital, and maintain our extremely selective and focused approach with $199 million of signed term sheets with venture growth stage companies in Q1. Given TPVG's leverage position, we are selectively allocating new commitments to TPVG with the majority going to other vehicles on the TriplePoint Capital platform and as a result for the first quarter closed debt commitments at TPVG is totaled $4 million. During the first quarter, we funded $57.6 million in debt investments to 11 portfolio companies, landing at the lower end of our guided range for the quarter, which carried an adjusted weighted average annualized portfolio yield of 14.1% at origination. Of the obligors funded during the quarter, roughly half generate annualized revenues in excess of $100 million reflecting the increased size and scale of our portfolio companies. Our core weighted average portfolio yield for Q1 was 14.7%, which was up from 14.2% in Q4 and represented our eighth consecutive quarterly increase. Our Q1 portfolio yield does not yet reflect the 2 – 25 basis point rate increases announced in February and March, which will more meaningfully impact portfolio yields starting in Q2. As a result, we are optimistic for another quarter of increased portfolio yield and for portfolio yield to continue to stay strong in 2023 given the rate environment. Although we didn't have any prepayments in Q1, they continue to be a part of the business and we still expect at least one to two customer prepayments per quarter with one previously announced prepayment expectation of ForgeRock's $30 million loan in conjunction with closing their take private transaction in addition to others in the works. In terms of our expectations for fundings in Q2 with our reduced allocation of new commitments to TPVG and low utilization of existing unfunded commitments, our forecast for gross investment fundings is in the range of $25 million to $75 million for the second quarter, down from our prior guidance of $50 million to $100 million with the potential to grow as we increase our allocation of new commitment to TPVG. During the quarter, we made continued progress on diversifying the TPVG portfolio by increasing the number of funded borrowers to 59 as compared to 48 one year ago. In addition, our top 10 obligors represent 32% of our total debt investments as compared to 40% one year ago. While not typical for venture growth stage companies, more than half of our top 10 obligors are either EBITDA positive or are projected to achieve EBITDA. We continue to see equity fundraising activity in our portfolio despite the challenging environment, although at lower levels in Q1, which we believe was also impacted by events associated with the venture banking market during the quarter. In Q1, seven portfolio companies raised approximately $64 million of capital. This brings the total to 32 portfolio companies rising over $1.6 billion of capital in the past year. We expect to see fundraising activity gradually pick up within our portfolio quarter-over-quarter over the course of the year. Our equity and warrant portfolio grows well with 155 warrant equity investments as of Q1 2023 as compared to 128 investments as of one year ago. As of March 31st, we held warrants in 107 companies, up from 86 companies as of Q1 2022, and held equity investments in 48 companies up from 42 companies as of Q1 2022 with a total cost and fair value of 71 million and 93 million respectively. During the quarter, we saw a reduction in the fair value of our warrant and equity positions reflecting market conditions as well as down rounds in some cases despite strong underlying performance from many of our portfolio companies. It's important to note that we continue to have numerous companies that are growing and expanding and executing according to and many cases ahead of plan, as well as achieving EBITDA, particularly those companies in the fintech, software, enterprise and travel segments, which is why we continue to expect our cumulative warrant and equity investments to generate realized gains in excess of our cumulative realized losses over the long-term. In terms of outlook for the portfolio and credit quality, given the environment for direct equity fundraising, the playbook for most of our portfolio companies is to continue to grow, but to do so thoughtfully while optimizing their cash burn rates to extend their runway to either achieve profitability or for a future equity rates. With this background, as of the end of the quarter, approximately 84% of our portfolio is ranked at our two best credit scores, which means that they are performing at or above expectations despite market conditions, and we upgraded one company from category two to category one with a principle balance of $15 million. As Jim mentioned, credit was impacted during the quarter due to conditions in the equity fundraising market, which we believe were also impacted by events in the venture banking market. We downgraded demand, also known as Luko, an insurtech company with principle balance of $17 million from category two to category three due to delays in its strategic financing process. We also downgraded RenoRun, a construction, technology and logistics company with principal balance of $3 million from Category 2 to Category 3. RenoRun has filed for creditor protection in Canada to facilitate a sale or liquidation process, and we look to our recovery on our loan, both from their cash on hand and other potential asset sales, including the entire enterprise and asset – and IP, sorry. Underground enterprises and the e-commerce retail with principle balance of $6 million was downgraded from Category 2 to Category 3 and has filed for Chapter 7 bankruptcy protection. We provided an inventory based financing facility to the company and look to recovery on our loan from the underlying inventory as well as other potential asset sales, including the entire enterprise and IP. Hey Favor, also known as Pill Club, an online pharmacy with the principle balance of $20 million filed for Chapter 11 bankruptcy protection with the intent to continue operations and potentially reorganize as a standalone enterprise or sell to another company. This is an ongoing situation and we expect more developments to occur in the near term that could result in substantial or full recovery of our loan. Also, during the quarter VanMoof an e-bike company with a principal balance of $23 million and Health IQ, an insured tech company with a principal balance of $25 million, which were both previously rated 3, were downgraded to Category 4 as they continue to navigate through challenges in their sectors and businesses as well as developments in their strategic financing processes. We are in a challenging period of time for venture capital investing and for public technology companies and expect some obligors to experience stress. As we have demonstrated before our teams have effectively managed through these situations. As a reminder, since TPVG inception now 10 years ago, our cumulative net loss rate remains under 3% of cumulative commitments or 32 basis points per annum and 2% of fundings or 22 basis points per annum. In closing, we remain focused on all aspects of our business and we'll continue to follow our long-term playbook with a focus on generating strong returns for shareholders, neither needs of venture growth stage companies, and further nurturing strong relationships with our select venture capital partners. With that, I'll now turn the call over to Chris.